Aaron Mann | Association for Accessible Medicines
THANK YOU - for all those who made our first-ever #GRxBiosims virtual conference a success.

Aaron Mann

AAM Board Member
Chief Executive Officer, Kindeva Drug Delivery
Aaron Mann
Aaron Mann
Kindeva Drug Delivery

Aaron Mann is the CEO of Kindeva Drug Delivery, a private company spun off from 3M in 2020 and backed by Altaris Capital Partners and 3M.

​At 3M, Aaron led the Drug Delivery Systems business and held responsibility for strategy and business development for the Health Care Business Group.

Prior to 3M, he ran corporate development, strategy and marketing at Phillips-Medisize, a global contract designer and manufacturer of drug delivery and medical device products, and led Operations at Remedi Senior Care, an institutional pharmacy. Aaron began his career at Bain & Company​.

Aaron holds a BA in Economics from Carleton College and an MBA from the Harvard Business School.

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.